Study of damage control strategy for non-traumatic diseases: a single-center observational study

Eur J Med Res. 2022 Oct 1;27(1):192. doi: 10.1186/s40001-022-00823-8.

Abstract

Background: Damage control strategy (DCS) has been introduced not only for trauma but also for acute abdomen, but its indications and usefulness have not been clarified. We examined clinical characteristics of patients who underwent DCS and compared clinical characteristics and results with and without DCS in patients with septic shock.

Methods: We targeted a series of endogenous abdominal diseases in Kansai Medical University Hospital from April 2013 to March 2019. Clinical characteristics of 26 patients who underwent DCS were examined. Then, clinical characteristics and results were compared between the DCS group (n = 26) and non-DCS group (n = 31) in 57 patients with septic shock during the same period.

Results: All 26 patients who underwent DCS had septic shock, low mean arterial pressure (MAP) before the start of surgery, and required high-dose norepinephrine administration intraoperatively. Their discharge mortality rate was 12%. Among the patients with septic shock, the DCS group had a higher SOFA score (P = 0.008) and MAP was lower preoperatively, but it did not increase even with intraoperative administration of large amounts of fluid replacement and vasoconstrictor. There was no significant difference in 28-day mortality and discharge mortality between the two groups.

Conclusions: DCS may be useful in patients with severe septic shock.

Keywords: Acute abdomen; Damage control strategy; Non-traumatic diseases; Open abdominal management; Septic shock.

Publication types

  • Observational Study

MeSH terms

  • Humans
  • Norepinephrine
  • Shock, Septic* / therapy
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Vasoconstrictor Agents
  • Norepinephrine